A framework for risk–benefit analysis of vaccines approved through accelerated pathways
Authors
Alexander Roberto Precioso (ORCID: https://orcid.org/0000-0001-8657-9292)
Rebecca E. Chandler (ORCID: https://orcid.org/0000-0002-9334-9046)
Henrik Salje
Oscar Cortes-Azuero
Albert Ko
Joseph Lewnard
Jose Luis Di Fabio
Stephen J. Thomas
J. Gabrielle Breugelmans
Nicole Lurie
Bethan Cracknell Daniels
Timothy Endy
Simon Cauchemez
Publication Details
Journal
Apollo (University of Cambridge)
Published
2025-06-10
Primary Topic
vaccines and immunoinformatics approaches
Type
article
Field-Weighted Citation Impact
0.00
Funders
Coalition for Epidemic Preparedness Innovations
European Commission
Agence Nationale de la Recherche
Direction Générale de l’offre de Soins
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
A framework for risk–benefit analysis of vaccines approved through accelerated pathways
Alexander Roberto Precioso, Rebecca E. Chandler, Henrik Salje, Oscar Cortes-Azuero et al.
Journal
Apollo (University of Cambridge)
Topics
vaccines and immunoinformatics approaches
article
A framework for risk–benefit analysis of vaccines approved through accelerated pathways
Alexander Roberto Precioso, Rebecca E. Chandler, Henrik Salje, Oscar Cortes-Azuero, Albert Ko, Joseph Lewnard, Jose Luis Di Fabio, Stephen J. Thomas, J. Gabrielle Breugelmans, Nicole Lurie, Bethan Cracknell Daniels, Timothy Endy, Simon Cauchemez
article en
Abstract
No abstract available for this paper.
Publication Tag
Apollo (University of Cambridge)
Funders
Coalition for Epidemic Preparedness Innovations, European Commission, Agence Nationale de la Recherche, Direction Générale de l’offre de Soins